SRRK
Scholar Rock Holding CorpCompany Information
- Company Name
- Scholar Rock Holding Corp
- CIK
- CIK0001727196
- Category
- Non-accelerated filer
- Ticker: Exchange
- SRRK: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- SRRK
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-10-07
- Last sale
- 2026-07-01
- Shares purchased (TTM)
- 142,624
- Shares sold (TTM)
- 470,489
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 132,416,066
- Shares outstanding
- 130,612,734
- Ownership
- 101.38%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 9.80%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 437 | 431 | 324 | 287 | 153 | 138 | 178 | 76 | 93 | 92 | 102 | 68 | ||||||
| Marketable Securities Current | 55 | 49 | 44 | 83 | 142 | 226 | 259 | 63 | 97 | 146 | 178 | 151 | ||||||
| Prepaid Expense And Other Assets Current | 15 | 35 | 18 | 21 | 24 | 21 | 14 | 14 | 9 | 9 | 8 | 10 | ||||||
| Assets Current | 507 | 515 | 385 | 391 | 319 | 385 | 451 | 153 | 199 | 247 | 288 | 228 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | ||||||
| Operating Lease Right Of Use Asset | 9 | 10 | 10 | 12 | 13 | 14 | 16 | 17 | 18 | 10 | 11 | 13 | ||||||
| Restricted Cash Noncurrent | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Other Assets Noncurrent | 3 | 5 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 1 | ||||||
| Assets | 524 | 535 | 404 | 412 | 340 | 408 | 475 | 179 | 227 | 267 | 311 | 251 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 11 | 9 | 10 | 7 | 1 | 4 | 10 | 4 | 3 | 3 | 3 | 2 | ||||||
| Accrued Liabilities Current | 55 | 44 | 40 | 50 | 44 | 28 | 31 | 29 | 22 | 21 | 20 | 17 | ||||||
| Operating Lease Liability Current | 6 | 6 | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 8 | 7 | 7 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | 2 | 6 | 1 | - | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities Current | 72 | 60 | 55 | 62 | 50 | 38 | 47 | 39 | 33 | 38 | 33 | 27 | ||||||
| Operating Lease Liability Noncurrent | 1 | 3 | 4 | 5 | 7 | 8 | 9 | 10 | 12 | 2 | 4 | 6 | ||||||
| Long Term Debt Noncurrent | 196 | 197 | 100 | 100 | 50 | 50 | 50 | 50 | 48 | 45 | 49 | 50 | ||||||
| Liabilities | 270 | 259 | 159 | 167 | 107 | 95 | 106 | 100 | 93 | 85 | 86 | 83 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1,769 | 1,681 | 1,546 | 1,454 | 1,341 | 1,310 | 1,291 | 935 | 925 | 916 | 901 | 798 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -1,516 | -1,406 | -1,301 | -1,210 | -1,107 | -997 | -923 | -856 | -792 | -733 | -676 | -630 | ||||||
| Stockholders Equity | 254 | 276 | 245 | 245 | 233 | 312 | 369 | 79 | 134 | 183 | 225 | 168 | ||||||
| Liabilities And Stockholders Equity | 524 | 535 | 404 | 412 | 340 | 408 | 475 | 179 | 227 | 267 | 311 | 251 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 150 | 150 | 300 | 150 | ||||||
| Common Stock Shares Issued | 122 | 119 | 108 | 99 | 96 | 95 | 94 | 80 | 80 | 80 | 76 | 56 | ||||||
| Shares Outstanding | 122 | 119 | 108 | 99 | 96 | 95 | 94 | 80 | 80 | 80 | 76 | 56 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialScholar Rock Holding Corp (SRRK) — SEC Financial Statements & Analysis
Scholar Rock Holding Corp (SRRK) is a biological products, (no diagnostic substances) company, incorporated in DE. Scholar Rock Holding Corp trades on Nasdaq as: SRRK. Scholar Rock Holding Corp (SRRK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Scholar Rock Holding Corp carries a market cap of $7.18B, a P/E ratio of -17.58x, a P/B ratio of 28.31x, an enterprise value of $6.94B, and an EV/EBITDA multiple of -17.14x. On profitability, it posts a Return on Equity (ROE) of -167.77%, a Return on Assets (ROA) of -94.63%, and a Return on Invested Capital (ROIC) of -594.07%. Per share, it reports EPS of $-3.13, diluted EPS of $-3.13, free cash flow per share of $-2.27, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 29.43% year-over-year, and EPS growth of 11.68% year-over-year. On the balance sheet, it maintains a current ratio of 7.02x, a quick ratio of 6.81x, working capital of $434.94M, a debt-to-equity ratio of 1.06x, a debt ratio of 0.52, an interest coverage ratio of -38.02x, free cash flow of $-297.01M (TTM), and net debt of $-244.69M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.18B
- P/E TTM
- -17.58x
- EPS TTM
- $-3.13
- P/B TTM
- 28.31x
- ROE TTM
- -167.77%
- ROA TTM
- -94.63%
- Debt To Equity
- 1.06x
- Free Cash Flow TTM
- $-297.01M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Scholar Rock Holding Corp in?
Scholar Rock Holding Corp (SRRK) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does SRRK trade on?
Scholar Rock Holding Corp (SRRK) trades on the Nasdaq.
Where is Scholar Rock Holding Corp incorporated?
Scholar Rock Holding Corp is incorporated in DE.
When was Scholar Rock Holding Corp (SRRK)'s most recent SEC filing?
Scholar Rock Holding Corp (SRRK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is SRRK's market cap?
Scholar Rock Holding Corp (SRRK) has a market capitalization of $7.18B as of 2026-06-30.
What is SRRK's EPS (earnings per share)?
Scholar Rock Holding Corp (SRRK)'s trailing twelve month EPS is $-3.13 as of 2026-06-30.
What is SRRK's ROE (return on equity)?
Scholar Rock Holding Corp (SRRK)'s trailing twelve month Return on Equity (ROE) is -167.77% as of 2026-06-30.
What is SRRK's ROA (return on assets)?
Scholar Rock Holding Corp (SRRK)'s trailing twelve month Return on Assets (ROA) is -94.63% as of 2026-06-30.
What is SRRK's ROIC (return on invested capital)?
Scholar Rock Holding Corp (SRRK)'s trailing twelve month Return on Invested Capital (ROIC) is -594.07% as of 2026-06-30.
What is SRRK's EV/EBITDA?
Scholar Rock Holding Corp (SRRK)'s trailing twelve month EV/EBITDA is -17.14x as of 2026-06-30.